Venmax Drugs and Pharmaceuticals Limited (BSE: 531015)
Health Care · Pharmaceuticals · IN
Rs14.40
-0.69% today · -31.3% 1Y
Venmax Drugs and Pharmaceuticals Limited (BSE: 531015) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.72M.
Over the last twelve months the share price has lost 31.3%, trading between 12.71 and 31.49.
Tweenvest scores Venmax Drugs and Pharmaceuticals Limited across four factors: quality 40/100, value 40/100. Its strongest factor is quality.
531015 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.72M
- Revenue (TTM)
- $982.95K
- P/E
- 58.93
- EPS
- 0.24
- Dividend yield
- —
- Beta (5Y)
- -1.61
- 52-week high
- Rs31.49
- 52-week low
- Rs12.71
- Avg volume (3M)
- —
- Shares outstanding
- 11.58M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Colinz Laboratories LimitedBSE: 531210 | $1.90M | Rs73.03 | -0.64% |
| Kanabo Group PlcLSE: KNB | $1.86M | £— | — |
| Delivra Health Brands Inc.TSXV: DHB | $1.86M | CA$0.09 | +6.25% |
| Artelo Biosciences, Inc.NasdaqCM: ARTL | $1.79M | $3.26 | -3.26% |
| Zenith Healthcare LimitedBSE: 530665 | $1.72M | Rs3.10 | -1.59% |
| Captor Capital Corp.CNSX: CPTR | $1.64M | CA$0.67 | +15.52% |
| Sunrest Lifescience LimitedNSEI: SUNREST | $1.63M | Rs36.75 | +3.52% |
| Desh Rakshak Aushdhalaya LimitedBSE: 531521 | $1.62M | Rs— | — |
Figures last refreshed Oct 11, 2026.